Memantine for the treatment of mild and mild-to-moderate Alzheimer's disease

Details for Australian Patent Application No. 2005204358 (hide)

International Classifications

Event Publications

27 July 2006 PCT application entered the National Phase

PCT publication WO2005/067908 Priority application(s): WO2005/067908

4 September 2008 Application Accepted

Published as AU-B-2005204358

8 January 2009 Standard Patent Sealed

3 December 2009 Offer to Surrender

Merz Pharma GmbH & Co. EckenKGaA heimer Landstrasse 100 , D-60318 Frankfurt , the Patentee of Letters Patent 2005204358 dated 18.12.2008 for an invention titled ' Memantine for the treatment of mild and mild-to-moderate Alzheimer's disease' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.

4 February 2010 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.